tradingkey.logo

Myomo Inc

MYO

1.955USD

+0.085+4.55%
Fechamento 08/04, 16:00ETCotações atrasadas em 15 min
67.33MValor de mercado
PerdaP/L TTM
Mais detalhes de Myomo Inc Empresa
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
Informações da empresa
Código da empresaMYO
Nome da EmpresaMyomo Inc
Data de listagemJun 12, 2017
CEOMr. Paul R. Gudonis
Número de funcionários184
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 12
Endereço137 Portland Street
CidadeBOSTON
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal02114
Telefone16179969058
Sitehttps://myomo.com/
Código da empresaMYO
Data de listagemJun 12, 2017
CEOMr. Paul R. Gudonis
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.21M
+14.96%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
374.42K
+8.62%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.21M
+14.96%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
374.42K
+8.62%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Herr Investment Group LLC
7.91%
Triple Gate Capital, LP
7.85%
Rosalind Advisors, Inc.
7.51%
AIGH Capital Management, LLC.
7.45%
The Vanguard Group, Inc.
3.51%
Other
65.77%
Investidores
Investidores
Proporção
Herr Investment Group LLC
7.91%
Triple Gate Capital, LP
7.85%
Rosalind Advisors, Inc.
7.51%
AIGH Capital Management, LLC.
7.45%
The Vanguard Group, Inc.
3.51%
Other
65.77%
Tipos de investidores
Investidores
Proporção
Hedge Fund
23.11%
Investment Advisor
19.85%
Investment Advisor/Hedge Fund
10.30%
Private Equity
7.45%
Individual Investor
7.41%
Research Firm
2.32%
Pension Fund
0.31%
Other
29.25%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
131
25.22M
70.09%
+1.15M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
2023Q1
64
6.64M
55.78%
+382.98K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Herr Investment Group LLC
2.85M
7.91%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.85%
--
--
Mar 31, 2025
Rosalind Advisors, Inc.
2.70M
7.51%
-295.28K
-9.85%
Mar 31, 2025
AIGH Capital Management, LLC.
1.72M
4.78%
-281.39K
-14.07%
Mar 31, 2025
The Vanguard Group, Inc.
1.26M
3.51%
--
--
Mar 31, 2025
Gudonis (Paul R)
1.21M
3.36%
+157.34K
+14.96%
Jun 11, 2025
Worth Venture Partners, LLC
1.19M
3.3%
-193.49K
-14.00%
Mar 31, 2025
Journey Advisory Group, LLC
1.12M
3.13%
+1.12M
--
Mar 31, 2025
Essex Investment Management Company, LLC
787.62K
2.19%
-6.08K
-0.77%
Mar 31, 2025
Soleus Capital Management, L.P.
704.27K
1.96%
-195.72K
-21.75%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.02%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Proporção0.02%
ProShares Hedge Replication ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI